Cargando…
Xm(2) Scores for Estimating Total Exposure to Multimodal Strategies Identified by Pharmacists for Managing Pain: Validity Testing and Clinical Relevance
OBJECTIVE: To assess the validity of an exposure score obtained from the Xm(2) tool for all pharmacological and nonpharmacological strategies used by individuals to manage chronic pain. METHODS: Using data from individuals with chronic pain, eXposure multimodal (Xm(2)) scores were calculated by assi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311733/ https://www.ncbi.nlm.nih.gov/pubmed/30651900 http://dx.doi.org/10.1155/2018/2530286 |
_version_ | 1783383655899463680 |
---|---|
author | Axon, David Rhys Bhattacharjee, Sandipan Warholak, Terri L. Slack, Marion K. |
author_facet | Axon, David Rhys Bhattacharjee, Sandipan Warholak, Terri L. Slack, Marion K. |
author_sort | Axon, David Rhys |
collection | PubMed |
description | OBJECTIVE: To assess the validity of an exposure score obtained from the Xm(2) tool for all pharmacological and nonpharmacological strategies used by individuals to manage chronic pain. METHODS: Using data from individuals with chronic pain, eXposure multimodal (Xm(2)) scores were calculated by assigning one point for every 100 mg of morphine equivalent used (opioid medications); 25% of the maximum recommended exposure used (nonopioid medications); and any use of another strategy then summed. Content, criterion, construct, and convergent validity were assessed. RESULTS: The sample of 149 individuals used a mean of 12.6 (SD = 4.6) strategies to manage pain and had a mean Xm(2) score of 16.8 (SD = 9.1). Content validity was established by demonstrating that the pain management strategies identified were also reported in the literature. Criterion validity was established by the positive association of exposure scores with the following: interference with work (odds ratio (OR) = 2.23, 95% confidence interval (CI) = 1.14–4.36), daily activities (OR = 2.10, CI = 1.07–4.13), relationships (OR = 1.98, CI = 1.01–3.88), and leisure activities (OR = 2.31, CI = 1.18–4.50); workdays missed (OR = 5.10, CI = 1.92–13.58); emergency department visits (OR = 3.40, CI = 1.17–9.91); hospitalizations (OR = 4.18, CI = 0.86–20.37); and by a negative association with satisfaction (OR = 0.40, CI = 0.18–0.88). Construct validity was established by the positive association of exposure with baseline pain intensity (p < 0.01) and odds of experiencing an adverse event (OR = 2.31, CI = 1.18–4.52). Convergent validity was established through correlations of pain intensity from the Xm(2) score and existing quantitative analgesic questionnaire (QAQ) score. DISCUSSION: Xm(2) scores represent a valid estimate of total exposure to multimodal strategies used and provide clinically relevant information for deciding what strategies to use at what level. |
format | Online Article Text |
id | pubmed-6311733 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-63117332019-01-16 Xm(2) Scores for Estimating Total Exposure to Multimodal Strategies Identified by Pharmacists for Managing Pain: Validity Testing and Clinical Relevance Axon, David Rhys Bhattacharjee, Sandipan Warholak, Terri L. Slack, Marion K. Pain Res Manag Research Article OBJECTIVE: To assess the validity of an exposure score obtained from the Xm(2) tool for all pharmacological and nonpharmacological strategies used by individuals to manage chronic pain. METHODS: Using data from individuals with chronic pain, eXposure multimodal (Xm(2)) scores were calculated by assigning one point for every 100 mg of morphine equivalent used (opioid medications); 25% of the maximum recommended exposure used (nonopioid medications); and any use of another strategy then summed. Content, criterion, construct, and convergent validity were assessed. RESULTS: The sample of 149 individuals used a mean of 12.6 (SD = 4.6) strategies to manage pain and had a mean Xm(2) score of 16.8 (SD = 9.1). Content validity was established by demonstrating that the pain management strategies identified were also reported in the literature. Criterion validity was established by the positive association of exposure scores with the following: interference with work (odds ratio (OR) = 2.23, 95% confidence interval (CI) = 1.14–4.36), daily activities (OR = 2.10, CI = 1.07–4.13), relationships (OR = 1.98, CI = 1.01–3.88), and leisure activities (OR = 2.31, CI = 1.18–4.50); workdays missed (OR = 5.10, CI = 1.92–13.58); emergency department visits (OR = 3.40, CI = 1.17–9.91); hospitalizations (OR = 4.18, CI = 0.86–20.37); and by a negative association with satisfaction (OR = 0.40, CI = 0.18–0.88). Construct validity was established by the positive association of exposure with baseline pain intensity (p < 0.01) and odds of experiencing an adverse event (OR = 2.31, CI = 1.18–4.52). Convergent validity was established through correlations of pain intensity from the Xm(2) score and existing quantitative analgesic questionnaire (QAQ) score. DISCUSSION: Xm(2) scores represent a valid estimate of total exposure to multimodal strategies used and provide clinically relevant information for deciding what strategies to use at what level. Hindawi 2018-12-12 /pmc/articles/PMC6311733/ /pubmed/30651900 http://dx.doi.org/10.1155/2018/2530286 Text en Copyright © 2018 David Rhys Axon et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Axon, David Rhys Bhattacharjee, Sandipan Warholak, Terri L. Slack, Marion K. Xm(2) Scores for Estimating Total Exposure to Multimodal Strategies Identified by Pharmacists for Managing Pain: Validity Testing and Clinical Relevance |
title | Xm(2) Scores for Estimating Total Exposure to Multimodal Strategies Identified by Pharmacists for Managing Pain: Validity Testing and Clinical Relevance |
title_full | Xm(2) Scores for Estimating Total Exposure to Multimodal Strategies Identified by Pharmacists for Managing Pain: Validity Testing and Clinical Relevance |
title_fullStr | Xm(2) Scores for Estimating Total Exposure to Multimodal Strategies Identified by Pharmacists for Managing Pain: Validity Testing and Clinical Relevance |
title_full_unstemmed | Xm(2) Scores for Estimating Total Exposure to Multimodal Strategies Identified by Pharmacists for Managing Pain: Validity Testing and Clinical Relevance |
title_short | Xm(2) Scores for Estimating Total Exposure to Multimodal Strategies Identified by Pharmacists for Managing Pain: Validity Testing and Clinical Relevance |
title_sort | xm(2) scores for estimating total exposure to multimodal strategies identified by pharmacists for managing pain: validity testing and clinical relevance |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311733/ https://www.ncbi.nlm.nih.gov/pubmed/30651900 http://dx.doi.org/10.1155/2018/2530286 |
work_keys_str_mv | AT axondavidrhys xm2scoresforestimatingtotalexposuretomultimodalstrategiesidentifiedbypharmacistsformanagingpainvaliditytestingandclinicalrelevance AT bhattacharjeesandipan xm2scoresforestimatingtotalexposuretomultimodalstrategiesidentifiedbypharmacistsformanagingpainvaliditytestingandclinicalrelevance AT warholakterril xm2scoresforestimatingtotalexposuretomultimodalstrategiesidentifiedbypharmacistsformanagingpainvaliditytestingandclinicalrelevance AT slackmarionk xm2scoresforestimatingtotalexposuretomultimodalstrategiesidentifiedbypharmacistsformanagingpainvaliditytestingandclinicalrelevance |